Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data.
Author(s): Tracy A, Subramanian A, Adderley NJ, Cockwell P, Ferro C, Ball S, Harper L, Nirantharakumar K
Source: Ann Rheum Dis 2018 Nov 28;
Publication date: 2018-11-28
Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome.
Author(s): Ugolini-Lopes MR, Santos LPS, Stagnaro C, Seguro LPC, Mosca M, Bonfá E
Source: Lupus 2018 Nov 15;:961203318811603
Publication date: 2018-11-15
Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.
Author(s): Pacheco-Lugo L, Sáenz-García J, Navarro Quiroz E, González Torres H, Fang L, Díaz-Olmos Y, Garavito de Egea G, Egea Bermejo E, Aroca Martínez G
Source: Lupus 2018 Nov 19;:961203318812679
Publication date: 2018-11-19
Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Author(s): Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A
Source: Kidney Int 2018 Nov 22;
Publication date: 2018-11-22
Towards a personalized treatment for IgA nephropathy considering pathology and pathogenesis.
Author(s): Coppo R
Source: Nephrol Dial Transplant 2018 Nov 26;
Publication date: 2018-11-26
Thematic areasHereditary glomerulopathies Immune glomerulopathies Tubulopathies Metabolic and stone disorders Thrombotic microangiopathies AD structural kidney disorders Renal malformations and ciliopathies Obstructive nephropathies Pediatric CKD and dialysis Pediatric kidney transplantation
Recently added publications